TANG CAPITAL PARTNERS LP 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | TANG CAPITAL PARTNERS LP | 1,753,335 2.500% | -2,584,820 (-59.58%) | Filing |
| 2023-11-24 1:49 pm Purchase | 2023-11-14 | 13G | Aclaris Therapeutics, Inc. ACRS | TANG CAPITAL PARTNERS LP | 4,338,155 6.100% | 4,338,155 (New Position) | Filing |